Sample size of 4 is too small to draw any conclusion from imo... but I wish that were the case!
Good summary of where aducanumab is at right now for anyone that's interested.
https://www.abc.net.au/news/health/2020-11-14/alzheimers-drug-aducanumab-faces-major-setback-with-
fda/12881536?utm_source=abc_news_web&utm_medium=content_shared&utm_content=twitter&utm_campaign=abc_news_web
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
0.045(2.53%) |
Mkt cap ! $304.7M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.84 | $1.78 | $94.78K | 52.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2014 | $1.82 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.84 | 1626 | 1 |
View Market Depth
| Last trade - 14.38pm 22/07/2025 (20 minute delay) ? |
| CGS (ASX) Chart |